PROM1 and breast carcinoma: Similarly, targeted paclitaxel delivery to breast cancer MCF-7 cells with anti-CD133 mAb targeting nanoparticles significantly reduced colony-forming potential and mammosphere formation compared to paclitaxel alone [257].